title: Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil.
authors.forename: Chika
authors.initials: C
authors.lastname: Kusakari
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Soda
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yamaguchi
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kitazaki
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Nakano
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Matsubara
authors.forename: Tomayoshi
authors.initials: T
authors.lastname: Hayashi
authors.forename: Toshiya
authors.initials: T
authors.lastname: Nagasaki
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nagayasu
authors.forename: Shigeru
authors.initials: S
authors.lastname: Kohno
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D018279:Carcinoma, Signet Ring Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004338:Drug Combinations; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008479:Mediastinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy; D008875:Middle Aged; D010094:Oxonic Acid / Q000008:administration & dosage*; D005641:Tegafur / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed
chemical_list: D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin